BMY

Bristol-Myers Squibb Co.

New York Stock Exchange

$78.68

Open: $79.11 High: $80.59 Low: $78.17 Close: $79.887

Range: 2022-06-27 - 2022-06-28

Volume:4,014,175

Market: Open

Get Free API Key

Download as Excel

BMY

Bristol-Myers Squibb Co. 430 E. 29TH STREET https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

CEO: Giovanni Caforio
Employees: 32,200
Sector: Healthcare
Industry: Drug Manufacturers

Latest Stocks Posts

View All Posts >

BMY News

Latest news about the BMY

7 Blue-Chip Stocks With Strong Dividend Yields
Blue-Chip stocks are particularly attractive in volatile times like now. These picks include a strong dividend as well.
by Investor Place at 6/9/22, 12:00 AMView More →
7 Cheap Growth Stocks That Won't Stay That Way for Long
Investors foolishly sent these stocks into cheap territory, ignoring the near-term growth prospects that will reward them soon.
by Investor Place at 6/6/22, 12:00 AMView More →
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way.
by Investor Place at 6/3/22, 12:00 AMView More →
The Top 10 Stocks Helping Warren Buffett Beat the Market
These Warren Buffett stocks are helping the Oracle of Omaha be a winner even in a down market. All are generating solid returns in 2022.
by Investor Place at 5/11/22, 12:00 AMView More →
3 Recession-Proof Dividend Stocks to Buy
ABM Industries, Bristol-Myers and UGI are three examples of companies that saw earnings-per-share grow by high rates during the 2007 to 2009 period. All three companies have extensive dividend growth track records and each stock yields higher than what the S&P 500 is paying.
by Investor Place at 4/8/22, 12:00 AMView More →
Best Stocks for 2022: Bristol-Myers Squibb Isn't Done Growing
It's been a great year for Bristol-Myers Squibb this year, but it's not too late to jump in. BMY stock offers a respectable dividend.
by Investor Place at 4/8/22, 12:00 AMView More →
7 Biotech Stocks to Buy With Key Catalysts for April
Biotech stocks are very sensitive to some key catalysts such as the FDA decision date, aka PDUFA date, clinical readouts/presentations and Adcom meeting. The month of April will see some companies belonging to the sector seeing some of these make-or-break catalysts.
by Investor Place at 4/5/22, 12:00 AMView More →
7 No-Brainer Stocks to Buy for April
Start your stock scan with companies showing strong quant scores in value, growth and quality, then buy those with strong catalysts.
by Investor Place at 4/4/22, 12:00 AMView More →
7 Michael Burry Stocks to Buy as 'The Big Short' Investor Makes Moves
So, which names now make up the Michael Burry stocks? Let's dive in, and check out these seven, the six that are U.S.-based, plus one foreign stock you can buy over-the-counter (OTC): Bristol-Myers Squibb (NYSE:BMY) CoreCivic (NYSE:CXW) Fidelity National Financial (NYSE:FNF) General Dynamics (NYSE:GD) Geo Group (NYSE:GEO) Imperial Brands (OTCMKTS:IMBBY) AEA-Bridges Impact (NYSE:IMPX)
by Investor Place at 3/17/22, 12:00 AMView More →
3 Top Stock Trades for This Week
Bulls seeking stock trades should focus on relative strength. Here are three stocks itching for new highs as the market sinks.
by Investor Place at 3/15/22, 12:00 AMView More →

S&P 500

NASDAQ 100

FTSE 100

QQQ

TESLA

BTC/USD

GBP/USD

GOLD